Autopsy report · NCT00308464
A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 5 months before it stopped.
- 136 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Growth Hormone Deficiency
- Interventions
- PHA-794428
- Participants
- 136
- Sites
- 35
- Countries
- Belgium, Czechia, Denmark, France, Germany, Italy, Netherlands, Poland, Slovakia, Spain, Sweden, United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.